Applications for the G4A Global Accelerator Are Now Open

Founded in 2013 in Berlin initially giving out grants to innovative healthcare apps, G4A Accelerator is now a global program dedicated to helping innovative health & care startups grow and enable positive disruption and progress within the digital health & care universe.

G4A Global Accelerator has two programs currently running for startups and companies. Join and change the experience of healthcare today. Accelerator applications close on May 31st!

G4A Accelerator

The 2018 Accelerator program aims to offer mentoring by entrepreneurs and Bayer experts, office space for 100 days, funding of 50,000€, and exclusive networking opportunities for your startup.

Over 100 Bayer experts are involved in the jury process to decide which companies Bayer will work with. Criteria of acceptance into the program include: company maturity, existing product prototypes, the team, as well as the applicant's fit to Bayer's areas of expertise and focus areas.

For further information and to apply, please visit:
https://bayer.agorize.com/en/challenges/g4a-global-accelerator-2018

G4A Dealmaker

The 2018 Dealmaker program is tailored for mature startups and companies that have a solution ready to go. The new Dealmaker is all about quality facetime between you and G4A experts for one full day. If there is a match, you will be invited to Berlin to pitch your solution, discuss collaboration options and close a deal. Travel stipends included!

For further information and to apply, please visit:
https://bayer.agorize.com/en/challenges/g4a-global-dealmaker-2018

Most Popular Now

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...